Teva launches first-to-file generic Cialis

Sep 27, 2018

Teva Pharmaceutical Industries announced the exclusive first-to-file launch of a generic version of Eli Lilly’s Cialis tablets in the U.S.

First-to-file status grants Teva a 180-day period of market exclusivity before the FDA approves another generic.

The launch builds on the generic giant’s portfolio, and follows an exclusive launch of a generic version of Viagra. According to Teva, the drugmaker  has the largest portfolio of FDA-approved generic products on the market and holds the leading position in first-to-file opportunities, with over 100 pending first-to-files in the U.S.

Read the press release

Want to get news like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments